Susan McElroy

Susan McElroy's AcademicInfluence.com Rankings

Susan McElroy

Biology

#5242

World Rank

#7673

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Susan McElroy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Susan Lynn McElroy is Chief Research Officer at Lindner Center of HOPE. Education and early career McElroy did her B.A. at Colgate University, Hamilton, and her M.D. at Cornell University Medical College, both in New York. This was followed by an internship in Internal Medicine at Columbia Presbyterian Hospital, and a residency in psychiatry at McLean Hospital, Massachusetts. She has also had fellowships at Cornell University Medical College, Harvard Medical School, and McLean Hospital.

(See a Problem?)

Susan McElroy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. (2000) (1309)
Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
Psychiatric features of individuals with problematic internet use. (2000) (855)
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. (2001) (703)
A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2000) (643)
Are mood disorders and obesity related? A review for the mental health professional. (2004) (633)
Compulsive buying: a report of 20 cases. (1994) (629)
Screening for bipolar disorder in the community. (2003) (607)
Olanzapine versus placebo in the treatment of acute mania (1998) (591)
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. (2000) (571)
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. (2001) (511)
Body dysmorphic disorder: 30 cases of imagined ugliness. (1993) (495)
Practice guideline for the treatment of patients with bipolar disorder (1994) (487)
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. (2003) (453)
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder (2000) (446)
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. (1992) (424)
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. (2003) (413)
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. (1998) (404)
Valproatereatment of Acute Mania: A Placebo-Controlled (1991) (373)
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. (2003) (352)
Correlates of overweight and obesity in 644 patients with bipolar disorder. (2002) (337)
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. (2007) (317)
Obsessive compulsive spectrum disorder. (1994) (313)
A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). (2010) (312)
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. (2002) (308)
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. (2010) (305)
Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder (2006) (300)
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline (2006) (299)
Twelve-month outcome after a first hospitalization for affective psychosis. (1998) (295)
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. (1986) (295)
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. (2006) (287)
Validity of the mood disorder questionnaire: a general population study. (2003) (286)
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). (2010) (281)
The impact of reproductive events on the course of bipolar disorder in women. (2002) (276)
Impact of bipolar disorder on a U.S. community sample. (2003) (269)
Early physical and sexual abuse associated with an adverse course of bipolar illness (2002) (266)
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study (2016) (258)
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. (2003) (244)
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. (2010) (240)
Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
Topiramate for the Treatment of Binge Eating Disorder Associated With Obesity: A Placebo-Controlled Study (2007) (240)
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. (1994) (237)
Co-occurrence of binge eating disorder with psychiatric and medical disorders. (2008) (231)
Relationships Among Negative, Positive, and Depressive Symptoms in Schizophrenia and Psychotic Depression (1996) (229)
Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders* (2003) (228)
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. (2015) (228)
Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder (2006) (223)
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. (2007) (222)
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure (2002) (221)
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. (2003) (217)
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. (2000) (210)
Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. (2003) (210)
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. (1998) (208)
Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. (2006) (206)
Open-label adjunctive topiramate in the treatment of bipolar disorders (2000) (205)
Kleptomania, compulsive buying, and binge-eating disorder. (1995) (205)
Risk factors for neuroleptic malignant syndrome. A case-control study. (1989) (198)
Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. (2003) (193)
Psychiatric and legal features of 113 men convicted of sexual offenses. (2004) (192)
Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. (2001) (190)
Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? (1995) (188)
Attention deficit hyperactivity disorder in adolescent mania. (1995) (186)
Differences and similarities in mixed and pure mania. (1995) (185)
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. (2005) (183)
Valproate in the treatment of acute mania. A placebo-controlled study. (1991) (181)
Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. (1998) (179)
Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. (1991) (179)
Familiality of temperament in bipolar disorder: support for a genetic spectrum. (2005) (179)
Suicidality among patients with mixed and manic bipolar disorder. (1996) (178)
The poor prognosis of childhood-onset bipolar disorder. (2007) (176)
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials (2015) (176)
Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. (1994) (175)
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. (2006) (173)
Kleptomania: a report of 20 cases. (1991) (173)
Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. (1999) (173)
Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations? (2005) (172)
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. (2001) (172)
Binge-eating disorder as a distinct familial phenotype in obese individuals. (2006) (170)
Treatment of binge-eating disorder with topiramate: a clinical case series. (2000) (169)
The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. (1992) (165)
Characteristics of 34 adults with psychogenic excoriation. (1998) (165)
A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. (2002) (164)
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCMTM-p) for longitudinal assessment of bipolar illness (2000) (164)
Placebo-controlled trial of sertraline in the treatment of binge eating disorder. (2000) (164)
Valproate in the Treatment of Bipolar Disorder: Literature Review and Clinical Guidelines (1992) (163)
Psychogenic Excoriation (2001) (160)
Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression (2003) (160)
Are impulse-control disorders related to bipolar disorder? (1996) (158)
Factors associated with pharmacologic noncompliance in patients with mania. (1996) (158)
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. (2000) (155)
Efficacy and safety of fluvoxamine in body dysmorphic disorder. (1998) (155)
Compliance with maintenance treatment in bipolar disorder. (1997) (153)
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. (2016) (153)
Sensitization, kindling, and anticonvulsants in mania. (1989) (152)
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. (2005) (152)
A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. (1996) (151)
Psychiatric features of 36 men convicted of sexual offenses. (1999) (151)
Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. (2001) (148)
Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. (2011) (147)
A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. (2003) (146)
Pharmacologic treatment of binge eating disorder. (2003) (145)
Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. (2008) (144)
GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores. (2019) (144)
Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. (2004) (142)
Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. (2007) (142)
Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. (2000) (141)
The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder (1999) (140)
Pharmacologic agents for the treatment of acute bipolar mania (2000) (139)
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. (2006) (139)
Treatment of Compulsive Shopping with Antidepressants: a Report of Three Cases (1991) (137)
A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. (1998) (135)
An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). (2003) (135)
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. (2000) (135)
Valproate oral loading in the treatment of acute mania. (1993) (134)
Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. (2006) (132)
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. (2001) (131)
Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia (2017) (129)
Valproate and Carbamazepine in the Treatment of Panic and Posttraumatic Stress Disorders, Withdrawal States, and Behavioral Dyscontrol Syndromes (1992) (127)
Topiramate in the long-term treatment of binge-eating disorder associated with obesity. (2004) (127)
Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. (2003) (126)
Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. (2000) (123)
A 1 year double‐blind placebo‐controlled fixed dose study of sertraline in the treatment of obsessive‐compulsive disorder (1995) (123)
Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study (2017) (122)
Clozapine in the treatment of dysphoric mania (1992) (122)
Chronology of comorbid and principal syndromes in first-episode psychosis. (1995) (121)
Personality disorders and traits in patients with body dysmorphic disorder. (2000) (120)
Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. (2009) (120)
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. (2009) (118)
Food addiction: Prevalence, psychopathological correlates and associations with quality of life in a large sample. (2018) (116)
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder (1994) (115)
Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder. (1997) (114)
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. (2001) (113)
The Stanley Foundation Bipolar Network (2001) (110)
Psychopathology in children of bipolar parents. (2007) (109)
Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder (2003) (109)
Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. (1995) (109)
Sodium valproate: its use in primary psychiatric disorders. (1987) (107)
Reproductive function and risk for PCOS in women treated for bipolar disorder. (2005) (107)
DSM-IV intermittent explosive disorder: a report of 27 cases. (1998) (105)
A Pilot Trial of Adjunctive Gabapentin in the Treatment of Bipolar Disorder (1997) (105)
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. (1996) (105)
Valproate in the treatment of behavioral agitation in elderly patients with dementia. (1995) (105)
A double-blind, placebo-controlled trial of topiramate for pathological gambling (2013) (102)
Obesity in Bipolar Disorder: An Overview (2012) (102)
Racial influence on diagnosis in psychotic mania (1995) (100)
Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. (2002) (100)
Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic (2003) (100)
The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
Characterizing impulsivity in mania. (2009) (98)
Olanzapine in treatment-resistant bipolar disorder. (1998) (97)
Twelve-month outcome in bipolar patients with and without personality disorders. (2000) (97)
Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. (2000) (96)
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. (2010) (95)
Guidelines for the recognition and management of mixed depression. (2017) (93)
The effects of race and information variance on disagreement between psychiatric emergency service and research diagnoses in first-episode psychosis. (1997) (93)
Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. (2002) (93)
A placebo-controlled study of trazodone in bulimia nervosa. (1989) (92)
Comorbidity of eating disorders with bipolar disorder and treatment implications. (2006) (90)
Recognition and treatment of DSM-IV intermittent explosive disorder. (1999) (89)
Frequency and presentation of neuroleptic malignant syndrome: a prospective study. (1987) (89)
Kleptomania: clinical characteristics and associated psychopathology (1991) (89)
Mania, psychosis, and antipsychotics. (1996) (87)
Binge eating disorder: a stable syndrome. (2006) (87)
Obesity in patients with severe mental illness: overview and management. (2009) (85)
Outcome in the Pharmacologic Treatment of Bipolar Disorder (1996) (85)
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers (2007) (85)
Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. (2013) (84)
Valproate treatment of panic disorder and lactate-induced panic attacks (1993) (84)
Valproate in the treatment of rapid-cycling bipolar disorder. (1988) (83)
Incidence of childhood-onset bipolar illness in the USA and Europe (2008) (83)
Role of Antiepileptic Drugs in the Management of Eating Disorders (2009) (81)
Medical comorbidity of binge eating disorder (2017) (81)
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial (2017) (81)
An open clinical trial of fluvoxamine treatment of psychogenic excoriation. (1999) (79)
High‐dose escitalopram in the treatment of binge‐eating disorder with obesity: a placebo‐controlled monotherapy trial (2008) (78)
Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder (2015) (76)
Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2 (2014) (75)
Anticonvulsants and antipsychotics in the treatment of bipolar disorder. (1998) (75)
Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. (2007) (75)
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. (2002) (74)
Open‐label pilot study of tramadol hydrochloride in treatment‐refractory obsessive‐compulsive disorder (1997) (74)
A Pilot Study of Topiramate as Monotherapy in the Treatment of Acute Mania (2001) (74)
Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups (2003) (74)
Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. (2014) (73)
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). (2015) (73)
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. (2012) (72)
Attention and formal thought disorder in mixed and pure mania (1995) (72)
Declining frequency of neuroleptic malignant syndrome in a hospital population. (1991) (71)
Olanzapine in the treatment of adolescent acute mania: a report of seven cases. (1999) (71)
Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. (1993) (71)
Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. (1996) (69)
Pharmacological management of binge eating disorder: current and emerging treatment options (2012) (69)
Outcome and Comorbidity in First- Compared with Multiple‐Episode Mania (1995) (69)
Gabapentin in the acute treatment of refractory bipolar disorder. (1999) (68)
A controlled study of phenomenology and family history in outpatients with bulimia nervosa. (1990) (68)
Head injury, bipolar disorder, and response to valproate. (1988) (68)
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. (2004) (67)
The psychiatric diagnoses of twenty-two adolescents who have sexually molested other children. (1999) (67)
Diagnosing and treating comorbid (complicated) bipolar disorder. (2004) (67)
Depression, Anxiety, Anger, and Somatic Symptoms in Patients with Body Dysmorphic Disorder (2004) (66)
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors (2020) (66)
Treatment of acute mania with gabapentin. (1997) (66)
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. (2009) (65)
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. (2009) (65)
Affective state dependence of the Tridimensional Personality Questionnaire (1995) (65)
Placebo effect in randomized, controlled studies of acute bipolar mania and depression (2000) (64)
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. (2009) (64)
Tiagabine in treatment refractory bipolar disorder: a clinical case series. (2002) (63)
Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. (2005) (63)
Antidepressants and suicidal behavior in bipolar disorder. (2006) (63)
Pharmacological approaches in the treatment of binge eating disorder. (2004) (63)
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. (2004) (62)
A 2‐year study of sertraline in the treatment of obsessive‐compulsive disorder (1997) (62)
New developments in the pharmacologic treatment of schizoaffective disorder. (1996) (62)
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance (2011) (62)
The role of gender in mixed mania. (2000) (62)
Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder. (2016) (61)
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. (2016) (61)
The effects of antecedent substance abuse on the development of first-episode psychotic mania. (1996) (61)
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. (2007) (61)
Current issues in the identification and management of bipolar spectrum disorders in 'special populations'. (2000) (61)
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder (2014) (60)
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial (2009) (60)
Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. (2005) (60)
Lamotrigine for the treatment of bipolar disorder: a clinical case series. (1999) (60)
Anticonvulsants in the treatment of bipolar disorder. (1992) (59)
Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. (2013) (59)
Time course of antipsychotic effects of neuroleptic drugs. (1989) (59)
Psychopharmacologic Treatment of Eating Disorders: Emerging Findings (2015) (59)
Clinical picture and etiologic models of mixed states. (1999) (58)
Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. (2008) (58)
Clinical phenotype of bipolar disorder with comorbid binge eating disorder. (2013) (58)
Body dysmorphic disorder: does it have a psychotic subtype? (1993) (57)
Neuroleptic malignant syndrome (1991) (57)
The Co-Occurrence of Mania with Medical and other Psychiatric Disorders (1994) (57)
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. (1997) (56)
Pharmacological treatment of kleptomania and bulimia nervosa. (1989) (56)
More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. (2014) (56)
Open Trial of Valproate in the Treatment of Adolescent Mania (1994) (56)
Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. (2011) (55)
Lycanthropy: alive and well in the twentieth century (1988) (55)
The Stanley Foundation Bipolar Network (2001) (55)
Phenomenology and comorbidity of adolescents hospitalized for the treatment of acute mania (1996) (55)
Overview of the treatment of binge eating disorder (2015) (54)
Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany (2011) (54)
Minimizing and managing antidepressant side effects. (1995) (54)
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. (2007) (54)
Neuroleptic malignant syndrome: long-term follow-up of 20 cases. (1991) (54)
Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. (2005) (53)
Poor quality of life and functioning in bipolar disorder (2017) (53)
Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders (2020) (53)
Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses (2015) (52)
Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder. (2016) (52)
Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? (1995) (52)
Differences in thyroid function between bipolar manic and mixed states (1998) (51)
Segmental linkage disequilibrium within the dopamine transporter gene (2002) (50)
Problem gambling in bipolar disorder: results from the Canadian Community Health Survey. (2007) (49)
Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network. (2016) (49)
Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo (2005) (49)
Valproate as a loading treatment in acute mania. (1993) (47)
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study (2007) (47)
Hospitalization Rates Among Clozapine-Treated Patients: A Prospective Cost-Benefit Analysis (1992) (47)
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder (2016) (46)
Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. (2007) (46)
Medical management of obesity associated with mental disorders. (2002) (46)
Are bipolar mood symptoms affected by the phase of the menstrual cycle? (2008) (45)
Possible synergism between fluoxetine and lithium in refractory depression. (1988) (45)
More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention (2017) (44)
Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study (2017) (44)
Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron. (1997) (44)
A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder. (2013) (44)
Racial disparities in bipolar disorder treatment and research: a call to action (2018) (43)
Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders (1993) (43)
Increased parental history of bipolar disorder in the United States: association with early age of onset (2014) (43)
Carbamazepine and valproate in the maintenance treatment of bipolar disorder. (2002) (43)
A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder (2014) (43)
The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: potential diagnostic and treatment implications. (1995) (42)
Perceived stress in body dysmorphic disorder. (1998) (42)
Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists. (2007) (42)
Valproate in psychiatric disorders: literature review and clinical guidelines. (1989) (42)
Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison. (2017) (41)
Symptom correlates of attentional improvement following hospitalization for a first episode of affective psychosis (1998) (41)
Advances in the pharmacologic treatment of bipolar depression (2003) (40)
Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. (2006) (40)
Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder (1999) (40)
Comparison of obese men and women with binge eating disorder seeking weight management (2007) (39)
Familial rates of affective and substance use disorders in patients with first-episode mania. (1999) (39)
Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study (2013) (39)
Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. (2012) (39)
Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. (1989) (38)
Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder (2000) (38)
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder (2020) (37)
Response of kleptomania and mixed mania to valproate. (1997) (37)
Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders. (2016) (37)
Update on Binge Eating Disorder. (2019) (37)
Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression (2011) (36)
Pharmacologic Treatments for Binge-Eating Disorder. (2017) (36)
Correlates of antimanic response to valproate. (1991) (36)
Examination of the clock gene Cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association (2005) (36)
Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally? (2000) (36)
Current pharmacotherapy options for bulimia nervosa and binge eating disorder (2012) (36)
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder (2017) (35)
Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder. (2015) (35)
Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder (2018) (35)
Ziprasidone: a new atypical antipsychotic (2001) (34)
Olanzapine vs placebo in the treatment of acute mania (1998) (34)
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. (2011) (33)
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. (2013) (33)
Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families (2008) (33)
Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree series (2003) (33)
Response of Recurrent Binge Eating and Weight Gain to Topiramate in Patients with Binge Eating Disorder after Bariatric Surgery (2005) (33)
Binge Eating Disorder. (2017) (33)
Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB. (2014) (32)
Health values of patients with bipolar disorder (2004) (32)
Olanzapine in the treatment of tardive dyskinesia: a report of two cases. (1999) (31)
Heritability and genome-wide SNP linkage analysis of temperament in bipolar disorder. (2013) (31)
Redefining mood stabilization. (2003) (31)
Treatment of panic disorder and benzodiazepine withdrawal with valproate. (1991) (30)
Validation of the yale-brown obsessive compulsive scale modified for binge eating. (2015) (30)
Emotional Eating and Emotional Eating Alternatives in Subjects Undergoing Bariatric Surgery (2007) (30)
Electrophysiologic abnormalities in bulimia and their implications for pharmacotherapy: A reassessment (1989) (30)
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine (2016) (30)
Comparison of patients with early-, typical-, and late-onset affective psychosis. (1997) (29)
International consensus group on depression prevention in bipolar disorder. (2011) (29)
Treatment guidelines for valproate in bipolar and schizoaffective disorders. (1993) (29)
The Bipolar Book History, Neurobiology, and Treatment (2015) (29)
An overview of the treatment of schizoaffective disorder. (1999) (29)
Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia? (1988) (28)
Multigenerational Positive Family History of Psychiatric Disorders Is Associated With a Poor Prognosis in Bipolar Disorder. (2015) (28)
Illness characteristics of patients in clinical drug studies of mania. (1995) (28)
Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder. (2019) (27)
Personality disorders in first- and multiple-episode mania (1996) (27)
Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial (2015) (27)
Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index (2016) (27)
Evening chronotype as a discrete clinical subphenotype in bipolar disorder. (2020) (27)
Treatment of Bulimia Nervosa with Trazodone: Short‐Term Response and Long‐Term Follow‐Up (1989) (27)
Conceptual foundations of obsessive–compulsive spectrum disorders. (1998) (27)
The relative influence of individual risk factors for attempted suicide in patients with bipolar I versus bipolar II disorder. (2018) (27)
Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa (2018) (26)
A Randomized, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain (2012) (26)
Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. (2012) (26)
Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. (1995) (26)
Antiepileptic drugs for the treatment of panic disorder. (1993) (26)
Clinical features of bipolar spectrum with binge eating behaviour. (2016) (26)
The mixed bipolar disorders (2000) (26)
Oral Loading Doses in the Valproate Treatment of Adolescents with Mixed Bipolar Disorder (1995) (26)
Heritability and linkage analysis of personality in bipolar disorder. (2013) (25)
Combined valproate and carbamazepine treatment of bipolar disorder. (1992) (25)
Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania. (2010) (25)
Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group. (2014) (25)
Health-economic implications of the onset of action of antimanic agents. (1996) (25)
Understanding the complexity of bipolar mixed episodes. (2008) (24)
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies (2013) (24)
Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder (2018) (24)
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores (2020) (24)
Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania. (2015) (23)
A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder. (2011) (23)
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder (2017) (23)
Hypomania associated with mirtazapine augmentation of sertraline. (1998) (23)
Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. (2010) (23)
Use of quetiapine in bipolar disorder: a case series with prospective evaluation. (2004) (23)
History of the development of valproate for treatment of bipolar disorder. (1995) (23)
An adolescent male with multiple paraphilias successfully treated with fluoxetine. (1998) (22)
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. (2016) (22)
More illness in offspring of bipolar patients from the U.S. compared to Europe. (2016) (22)
Genome-wide association study identifies 30 loci associated with bipolar disorder (2019) (22)
Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction (2017) (21)
Psychotherapy use in bipolar disorder: Association with functioning and illness severity (2015) (21)
A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the behave-ad and CGI rating scales (1997) (21)
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders (2021) (21)
Epidemiology of Neuroleptic Malignant Syndrome (1991) (21)
Diagnostic and treatment implications of psychiatric comorbidity with migraine. (1994) (21)
Bipolar Disorders: Special Diagnostic and Treatment Considerations in Women (2004) (21)
Pharmacologic loading in the treatment of acute mania. (2000) (21)
Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state (2018) (21)
Testing a clinical staging model for bipolar disorder using longitudinal life chart data (2018) (20)
The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder (2017) (20)
Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study (2015) (20)
Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. (2016) (20)
More Medical Comorbidities in Patients With Bipolar Disorder From the United States Than From the Netherlands and Germany (2014) (20)
Methodological issues in developing new acute treatments for patients with bipolar illness (2000) (20)
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder (2016) (20)
Genetic Risk Score Analysis in Early-Onset Bipolar Disorder. (2017) (20)
Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8 (2018) (20)
Recovered memory therapy: False memory syndrome and other complications. (1995) (20)
Adjunctive Methylphenidate in the Treatment of Bulimia Nervosa Co-occurring with Bipolar Disorder and Substance Dependence. (2013) (20)
Pharmacologic treatment of schizoaffective disorder (1994) (19)
A pilot study of rapid lithium administration in the treatment of acute mania. (2001) (19)
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study (2018) (19)
Investigational drugs for the treatment of binge eating disorder (BED): an update (2019) (19)
Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder (2013) (18)
What makes a drug a primary mood stabilizer? (2002) (18)
Bipolar mixed episodes: characteristics and comorbidities. (2007) (18)
A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder. (2014) (18)
Treatment of bipolar depression (1998) (18)
Plastic surgery and psychotherapy in the treatment of psychologically disturbed patients. (1992) (18)
Armodafinil in binge eating disorder: a randomized, placebo-controlled trial (2015) (18)
Increases in multiple psychiatric disorders in parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany (2015) (18)
Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype? (2005) (18)
Divalproex sodium in sex offenders with bipolar disorders and comorbid paraphilias: an open retrospective study. (2001) (18)
Binge eating disorder in elderly individuals. (2012) (17)
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. (2016) (17)
Treatment of psychiatric disorders with valproate: a series of 73 cases (1988) (17)
Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder (2017) (17)
Successful Treatment of Binge Eating Disorder With Combination Phentermine/Topiramate Extended Release. (2015) (17)
Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: comparisons to matched patients with bipolar disorder (1999) (17)
The New Antipsychotics and Their Therapeutic Potential (1997) (17)
Association of brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism with early‐onset bipolar disorder (2015) (17)
Age at Onset of Bipolar Disorder Related to Parental and Grandparental Illness Burden. (2016) (17)
Managing metabolic abnormalities in the psychiatrically ill : a clinical guide for psychiatrists (2007) (17)
Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. (2018) (17)
Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial (2016) (17)
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. (2014) (16)
Desipramine treatment for relapse prevention in cocaine dependence. (1989) (16)
Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial. (2020) (16)
Schizoaffective disorder: role of atypical antipsychotics (1999) (16)
Postpartum depression with bipolar disorder. (2001) (16)
Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity (2006) (16)
Further Evidence of a Cohort Effect in Bipolar Disorder: More Early Onsets and Family History of Psychiatric Illness in More Recent Epochs. (2016) (16)
New approaches in managing bipolar depression. (2003) (16)
Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network (2019) (16)
New uses for antidepressants: social phobia. (1997) (16)
Clinical correlates of acute bipolar depressive episode with psychosis. (2017) (15)
Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cycling (2019) (15)
Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder (2018) (15)
New findings from the bipolar collaborative network: Clinical implications for therapeutics (2006) (15)
A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation (2017) (15)
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. (2017) (15)
Response to commentary: "Using questionnaires to screen for psychiatric disorders" (2004) (15)
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder (2017) (15)
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. (2008) (15)
Validity, Reliability, and Responsiveness of a New Measure of Health-Related Quality of Life in Children with Immune Thrombocytopenic Purpura: The Kids' ITP Tools (2007) (15)
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial (2020) (15)
Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study. (2018) (15)
Orlistat misuse in bulimia nervosa. (2002) (15)
A linkage disequilibrium study of bipolar disorder and microsatellite markers on 22q13 (2002) (14)
High-dose fluoxetine: safety and efficacy in 27 cases. (1991) (14)
Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14 (2009) (14)
Misattribution of eating and obsessive-compulsive disorder symptoms to repressed memories of childhood sexual or physical abuse (1995) (14)
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network (2007) (14)
The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. (2020) (14)
Therapeutic potential of new second generation antipsychotics for major depressive disorder (2010) (13)
A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model. (2017) (13)
Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation. (1992) (13)
Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder (2019) (13)
Presentations of depression in bipolar illness (2002) (13)
Association between history of psychosis and cardiovascular disease in bipolar disorder (2015) (13)
Antiepileptic drugs to treat psychiatric disorders (2008) (13)
Atypical Antipsychotics in the Treatment of Bipolar Disorder (2000) (13)
A double‐blind, placebo‐controlled trial of eicosapentanoic acid in rapid cycling bipolar disorder (2002) (13)
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (2021) (12)
Obesity and mental disorders (2006) (12)
Bulimia nervosa presenting as rectal purging and rectal prolapse: case report and literature review. (2012) (12)
Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. (2019) (12)
Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis (2019) (12)
National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank (2015) (12)
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials (2020) (12)
Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder (2020) (12)
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. (2019) (12)
Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study. (2013) (11)
Mitochondrial DNA sequence data reveals association of haplogroup U with psychosis in bipolar disorder. (2017) (11)
Treatment of Bipolar Disorder (2009) (11)
Current Perspectives on Treatment of Bipolar Disorder with Lithium (1993) (11)
Binge eating disorder pharmacotherapy clinical trails--who is left out? (2009) (11)
The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder (2020) (11)
Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management. (2007) (11)
Adding Increased Energy or Activity to Criterion (A) of the DSM-5 Definition of Hypomania and Mania: Effect on the Diagnoses of 907 Patients From the Bipolar Collaborative Network. (2019) (11)
Use of Anticonvulsants in Psychiatry: Recent Advances (1988) (11)
Double jeopardy in the United States: Early onset bipolar disorder and treatment delay (2020) (11)
Long-term pharmacotherapy of bulimia nervosa. (1989) (11)
Divalproex in the treatment of bipolar disorder. (2003) (10)
Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature. (2018) (10)
Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder (2018) (9)
Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. (2017) (9)
Treating Nonsuicidal Self-Injury (2014) (9)
Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. (2015) (9)
Long‐term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study (2021) (9)
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection (2020) (8)
Bipolar disorder. (2001) (8)
Nonsteroidal anti‐inflammatory drugs (NSAIDs) and paracetamol do not affect 6‐month mood‐stabilizing treatment outcome among 482 patients with bipolar disorder (2017) (8)
The epidemic of depression with obesity. (2015) (8)
Managing comorbid obesity and depression through clinical pharmacotherapies (2016) (8)
Porcine stress syndrome: An animal model for the neuroleptic malignant syndrome? (1990) (8)
Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study (2020) (8)
Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders (2020) (8)
Characterisation of age and polarity at onset in bipolar disorder (2021) (7)
Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review. (2019) (7)
The role of childhood adversity in the development of medical comorbidities associated with bipolar disorder (2012) (7)
Pros and cons of approved therapies for bipolar depression and ongoing unmet needs. (2014) (7)
Placebo cessation in binge eating disorder: effect on anthropometric, cardiovascular, and metabolic variables. (2015) (7)
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. (2020) (7)
Dysphoric mania, mixed states, and mania with mixed features specifier: are we mixing things up? (2016) (7)
Further evidence for linkage of bipolar disorder to chromosomes 6 and 17 in a new independent pedigree series (2012) (7)
Definition, evaluation, and management of treatment refractory mania. (2001) (7)
170 Efficacy and Safety of Dasotraline in Adults with Binge-Eating Disorder: A Randomized, Double-blind, Fixed-dose Trial (2020) (6)
A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder (2019) (6)
Treatment outcomes of acute bipolar depressive episode with psychosis (2018) (6)
N-acetylcysteine in bulimia nervosa--open-label trial. (2013) (6)
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. (2016) (6)
Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials. (2018) (6)
Genome-wide association study of suicide attempt in psychiatric disorders identifies association with major depression polygenic risk scores (2018) (6)
The impact of sample processing on inflammatory markers in serum: Lessons learned (2019) (6)
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative (2022) (6)
The potential role of stimulants in treating eating disorders. (2021) (6)
25 Years of the International Bipolar Collaborative Network (BCN) (2021) (6)
Brain Electrical Activity Mapping (BEAM) in Bulimia Nervosa (1991) (6)
Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities (2016) (6)
Body mass index and blood pressure in bipolar patients: Target cardiometabolic markers for clinical practice. (2020) (6)
Bipolarity in Women: Therapeutic Issues (2006) (6)
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach (2022) (6)
Psychotic Depression (1997) (5)
Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications. (2019) (5)
Relationship of comorbid personality disorders to prospective outcome in bipolar disorder. (2020) (5)
Factor analysis of the eating disorder diagnostic scale in individuals with bipolar disorder. (2019) (5)
P0161 - A double-blind, placebo-controlled study with acute and continuation phase of Quetiapine and Paroxetine in adults with bipolar depression (Embolden II) (2008) (5)
451. Treatment of Binge Eating Disorder (2017) (5)
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials (2020) (5)
Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States. (2014) (5)
Pharmacoeconomic Aspects of the Treatment of Bipolar Disorder (1996) (5)
RECOGNITION AND TREATMENT OF INTERMITTENT EXPLOSIVE DISORDER AND EXPLOSIVITY (1999) (5)
Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorder (2019) (5)
P.2.e.023 Placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN II) (2008) (5)
113 Dasotraline for the Treatment of Moderate to Severe Binge Eating Disorder in Adults: Results From a Randomized, Double-Blind, Placebo-Controlled Study (2018) (5)
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders (2021) (4)
Establishing a Multi-Site Investigation of the Neural Mechanisms Underlying Response to Electroconvulsive Therapy (2017) (4)
Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder (2013) (4)
Reply to "The Nosology of Compulsive Skin Picking" (1999) (4)
P-6-9 Double-blind comparison of fluvoxamine and clomipramine in obsessive compulsive disorder in the United States (1995) (4)
An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate (2019) (4)
Antiepileptic Drugs in Obesity, Psychotropic-Associated Weight Gain, and Eating Disorders (2008) (4)
Reliability, Validity, and Classification Accuracy of a Measure of DSM-IV Diagnostic Criteria for Pathological Gambling (2003) (4)
Medical comorbidity of binge eating disorder: response (2017) (4)
Differences in thyroid function studies in acutely manic adolescents with and without attention deficity hyperactivity disorder (ADHD). (1996) (4)
What treatment data support topiramate in bulimia nervosa and binge eating disorder? What is the drug's safety profile? How is it used in these conditions? (2003) (4)
Valproate in the Treatment of Behavioral Agitation of Dementia (1996) (4)
Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder (2018) (4)
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response. (2021) (4)
More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring (2018) (4)
P-6-14 Long-term sertraline treatment of obsessive compulsive disorder: A 2 year study (1995) (4)
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome. (2021) (4)
The costs of treatment of bipolar disorder (2000) (4)
Clinical phenotype and genetic risk factors for bipolar disorder with binge eating: an update (2019) (3)
THE NOSOLOGY OF COMPULSIVE SKIN PICKING. AUTHORS' REPLY (1999) (3)
Lamictal Monotherapy in the treatment of bipolar disorder (1997) (3)
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials (2019) (3)
Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania (2022) (3)
The genetics of bipolar disorder with obesity and type 2 diabetes. (2022) (3)
Dynamic insulin‐stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorder (2021) (3)
A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa. (2021) (3)
Dr. Phillips and Colleagues Reply (1994) (3)
Placebo response and cessation in binge eating disorder: A pooled analysis of two randomized parallel-group clinical trials. (2018) (3)
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study (2021) (3)
Reply to Letter to the Editor "The Nosology of Compulsive Skin Picking" (1999) (3)
Pharmacotherapy of the Eating Disorders (2010) (3)
Treating bipolar disorder in the primary care setting: the role of aripiprazole. (2009) (2)
Switch rate on venlafaxine compared with bupropion and sertraline (2004) (2)
Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say? (2014) (2)
P.1.133 Lamictal® monotherapy in the treatment of bipolar disorder (1997) (2)
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes (2022) (2)
Comprar Antiepileptic Drugs to Treat Psychiatric Disorders | Susan L. McElroy | 9780849382598 | Informa Healthcare (2008) (2)
Bipolar Disorder with Co-Occurring Eating Disorders: Prevalence and Pharmacotherapeutic Implications (2011) (2)
Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach. (2017) (2)
Dr. Phillips and Dr. McElroy Reply (2006) (2)
Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy (2023) (2)
The dual epidemic of tobacco dependence and obesity among those with severe mental illness. (2016) (2)
Valproate in the Treatment of Bipolar Disorder (1992) (2)
The Modernization of Clozapine (2022) (2)
Dr. Keck and Associates Reply (1988) (2)
Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder (2022) (1)
P.2.e.022 Placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN I) (2008) (1)
Dr. McElroy and Associates Reply (1993) (1)
448. Evidence for a Role of Binge Eating and Obesity in Bipolar Disorder Genetic Risk: Genome-wide Associations in PRR5-ARHGAP8 and TCF7L2 (2017) (1)
The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder. (2021) (1)
Understanding and coping with binge eating disorder: the patient's perspective. (2015) (1)
Prevalence rate of mixed depression and its impact on remission: a controlled evaluation (2009) (1)
The range of hypo/manic severities on antidepressants by the daily LCM (2004) (1)
Erratum: Efficacy of olanzapine in acute bipolar maniana double-blind, placebo-controlled study (Archives of General Psychiatry (2000) 47 (841-849)) (2002) (1)
Polygenic scores for major depressive disorder and depressive symptoms predict response to lithium in patients with bipolar disorder (2018) (1)
BODY DYSMORPHIC DISORDER : SYMPTOM OR SYNDROME. AUTHORS' REPLY (1994) (1)
Diagnosing and treating major depressive episodes that lie along the mood disorders spectrum: focus on depression with mixed features (2021) (1)
Mood stabilizer and subsequent need for adjunctive antidepressant: naturalistic follow up of the SFBN (2007) (1)
Medication for Binge Eating (2020) (1)
Are personality disorders in bipolar patients more frequent in the US than Europe? (2022) (1)
Diagnosis and treatment strategies for mixed episodes in bipolar disorder. (2007) (1)
5.9 CLINICAL CORRELATES AND COMORBIDITIES OF EARLY- VERSUS LATE-ONSET BIPOLAR DISORDER USING THE MAYO CLINIC BIPOLAR BIOBANK (2016) (1)
Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients severity of illness. (2017) (1)
A Comparison of “Second Generation Antipsychotics” in the Treatment for Bipolar Disorder: Focus on Clozapine, Quetiapine, Ziprasidone and Aripiprazole (2006) (1)
Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder. (2015) (1)
Mixed depression in bipolar disorder : prevalence rate and clinical correlates during naturalistic follow up (2010) (1)
Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder. (2015) (1)
Research report Problem gambling in bipolar disorder: Results from the Canadian Community Health Survey (2007) (1)
The use of melatonin to mitigate the adverse metabolic side effects of antipsychotics. (2021) (1)
New uses for antidepressants : Social phobia. Discussion (1997) (1)
429. An open-label study of fluvoxamine in body dysmorphic disorder (1996) (1)
Characterization of Age and Polarity at Onset in Bipolar Disorder (2021) (1)
Pharmacotherapy for Eating Disorders (2018) (1)
High genetic loading of schizophrenia predicts poor response to lithium in patients with bipolar disorder: A polygenic score and cross-trait genetic analysis (2017) (1)
Antiepileptics in the Treatment of Epilepsy (2008) (1)
Erratum: "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar i or II disorder: Results from the bipolar CHOICE trial" [Journal of Affective Disorders (2014) 161 (30-35)] (2014) (1)
Subsyndromal depression and impaired life functioning in bipolar disorder (2005) (1)
Original Article A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder (2019) (1)
Mania and bipolar depression: complementing not opposing poles—a post-hoc analysis of mixed features in manic and hypomanic episodes (2021) (1)
A matter of time: A systematic scoping review on a potential role of the circadian system in binge eating behavior (2022) (1)
PUTATIVE PREDICTORS OF RESPONSE TO MAINTENANCE MEDICATIONS (0)
Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorder (2019) (0)
STATISTICAL ANALYSIS OF X CHROMOSOME VARIANTS: APPLICATION TO SEX-SPECIFIC CHARACTERISTICS OF BIPOLAR DISORDER (2019) (0)
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder (2022) (0)
Behavioral Weight Management of Obese Patients with Mental Disorders (2006) (0)
More Stressors and Bipolar Illness Adversity in US than Europe (2011) (0)
Increased risk factors and poor long-term outcome in the US compared to Holland and Germany (2010) (0)
CHOICE ) : A pragmatic trial of complex treatment for a complex disorder Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (2013) (0)
Insulin resistance in bipolar disorder: A systematic review of illness course and clinical correlates. (2023) (0)
Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies. (2022) (0)
Bipolar Disorder and Eating Disorders (2015) (0)
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. (2021) (0)
Supplementary Table 3 (2015) (0)
Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity. (2021) (0)
43. Overview of Data Supporting the Efficacy of Lisdexamfetamine Dimesylate in the Treatment of Binge Eating Disorder (2017) (0)
SA31 GENETIC VARIANTS AS MODIFIERS OF THE ASSOCIATION OF BODY MASS INDEX WITH BIPOLAR DISORDER (2019) (0)
Sex Offenders (1998) (0)
Research report Psychopathology in children of bipolar parents (2007) (0)
Hirschsprung Disease and Eating Disorders (2021) (0)
Psychopharmacology across the Life Span (1997) (0)
The link between suicidality and bipolar disorders (1996) (0)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders (2023) (0)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders (2023) (0)
Rapid cycling bipolar disorder: a 5-year prospective follow-up (2004) (0)
Treatment of Mania (2015) (0)
P.1.a.029 Genetics of specific clinical phenotypes of bipolar disorder: a focus on mania with psychosis (2017) (0)
An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials (2022) (0)
Weight changes in adults with major depressive disorder: A systematic review and meta-analysis of prospective studies. (2023) (0)
Psychotic disorders: Many forms, common themes (1996) (0)
Efficacy and Safety of Lisdexamfetamine for Treatment of AdultsWithModerate to Severe Binge-Eating Disorder A Randomized Clinical Trial (2015) (0)
Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. (2018) (0)
Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating Disorder. (2020) (0)
Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors (2023) (0)
Recent Advances in Depressive Disorder (2019) (0)
Supplementary Table 1 (2015) (0)
Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder. (2021) (0)
Treatment of Acute Manic and Mixed Episodes (2008) (0)
Optimizing Binge Eating Disorder Drug Development using a Quantitative Disease-Drug-Trial Model (2017) (0)
Comparing the known efficacy of antiepileptic agents in bipolar disorder (0)
Eating Disorders: Binge Eating (2014) (0)
P.1.214 Lamotrigine controls bipolar depression without destabilising mood: An analysis of data from 8 placebo-controlled trials (2003) (0)
Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study (2023) (0)
Bipolar Disorder: An Update on Recent Therapeutic Trials (2011) (0)
Broadening bipolar diagnostic criteria: why not start with hypomania? (2011) (0)
Gabapentin ( Neurontin ® ) in the acute treatment of refractory bipolar disorder (0)
Frequency of the neuroleptic malignant syndrome, 1963-1986 (1987) (0)
Switch rates of new-generation antidepressants in adjunctive treatment of bipolar depression (2006) (0)
Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder (2023) (0)
Chronology of principal and comorbid syndromes in first-episode psychosis (1994) (0)
Management and treatment of feeding and eating disorders (2020) (0)
Clinical implications of treatment guidelines for pediatric bipolar disorder and the expert consensus guidelines for bipolar disorder (2005) (0)
Bipolar illness in the United States compared to the Netherlands and Germany (2011) (0)
Neurobiology of Bipolar Disorder (2020) (0)
Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists (2008) (0)
Four generations of US patients are more ill than those from the Netherlands and Germany (2016) (0)
Use of quetiapine in bipolar disorder: a case series with prospective evaluation : a case series with prospective evaluation (2004) (0)
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response (2021) (0)
Nature and Frequency of Impulsive Behaviors in Healthy Young Adults: (622192009-001) (2013) (0)
Differences in perceived life stress in bipolar I and II disorder: Implications for future epigenetic quantification (2022) (0)
University of Groningen Role of childhood adversity in the development of medical comorbidities associated with bipolar disorder (2017) (0)
Polysomnography Features of Excessive Daytime Somnolence Associated with Monoamine Oxidase Inhibitor Treatment (1992) (0)
Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants. (2019) (0)
Obesity and Mood Disorders (2006) (0)
Questions & Answers (2003) (0)
In Memoriam: Charles Bowden, MD (1938-2022). (2022) (0)
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder. (2022) (0)
Reply (2002) (0)
| Antiepileptic Drugs to Treat Psychiatric Disorders | Taylor & Francis Group (2016) (0)
SU26 A WHOLE GENOME SEQUENCING STUDY IDENTIFIES A RARE VARIANT IN ANK3 THAT MAY CONTRIBUTE TO BIPOLAR DISORDER (2019) (0)
Impulse control disorders (2012) (0)
SA30 GENETIC HETEROGENEITY OF BIPOLAR DISORDER: A FOCUS ON MANIC PSYCHOSIS AND THE SIMILARITIES TO SCHIZOPHRENIA (2019) (0)
Dermatitis Pressure ulcers Endocrine disorders Type 2 diabetes Dyslipidemia Metabolic syndrome Gynecological problems Abnormal menses Infertility Polycystic ovary syndrome Pregnancy complications Pulmonary disease Hypoventilation syndromes Obstructive sleep apnea Other conditions Osteoarthritis Gout (2009) (0)
Comparison of Demographic and Clinical Features of Bipolar Disorder in Persons of African and European Ancestry (2022) (0)
Genome-wide interactions with body mass index and bipolar disorder risk : a study from the psychiatric genomics consortium bipolar disorder working group (2018) (0)
T24DISSECTING SUB-PHENOTYPES OF BIPOLAR DISORDER USING MULTIPLE POLYGENIC RISK SCORES (2019) (0)
2. Non-Invasive Spinal Cord Stimulation for Major Depressive Disorder: A Pilot Randomized Controlled Trial (2023) (0)
Background Few studies have examined the relative risks of switching into hypomania ormania associatedwith second-generation antidepressantdrugs in bipolardepression. Aims To examine therelative acute effects of bupropion, sertraline and venlafaxine as adjuncts tomood (2006) (0)
Mood stabilisation with lamotrigine in rapid cycling bipolar disorder (2000) (0)
Edinburgh Research Explorer Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia (2017) (0)
Stanley foundation bipolar network: predictors of psychosocial outcome (2016) (0)

This paper list is powered by the following services:

Other Resources About Susan McElroy

en.wikipedia.org

Susan McElroy's Academic­Influence.com Rankings

Why Is Susan McElroy Influential?

Susan McElroy's Published Works

Published Works

Other Resources About Susan McElroy

Susan McElroy's AcademicInfluence.com Rankings